Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.16.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XBB.1.16.9NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GK.6ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
GK.6ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
GK.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GK.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GK.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GK.6NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EG.5.2.1ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
EG.5.2.1ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
EG.5.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.2.1NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EG.5.2.1NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HW.1.2ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HW.1.2ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HW.1.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
HW.1.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HW.1.2NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HW.1.2NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
HN.7ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
HN.7ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
HN.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
HN.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
HN.7NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
HN.7NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
GE.1.6ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
GE.1.6ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
GE.1.6ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GE.1.6ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GE.1.6NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
GE.1.6NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
EG.5.1.9ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
EG.5.1.9ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
EG.5.1.9ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.9ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.9NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
EG.5.1.9NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
XCHORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-5786.4Germany
XCHORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-5057.65Germany
XCHECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCHECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCHNCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
XCHNCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
JF.3ORF1abCharité-ORF1bGTGARATGGTCATGTGTGGCGG2254.551543115452F-17266.7Germany
JF.3ORF1abCharité-ORF1bCARATGTTAAASACACTATTAGCATA2623.081553015505R-9191.15Germany
JF.3ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
JF.3ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
JF.3NCorman-NCACATTGGCACCCGCAATC1957.892870628724F-23131.5Germany
JF.3NCorman-NGAGGAACGAGAAGAGGCTTG20552883328814R-22527.5Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used